PDF(2225 KB)
PDF(2225 KB)
PDF(2225 KB)
儿童心肌致密化不全6例临床表现及基因变异分析
Clinical manifestations and gene mutation analysis of children with noncompaction of the ventricular myocardium: an analysis of 6 cases
该文总结分析儿童心肌致密化不全（NVM）的临床和基因变异特点。6例NVM患儿起病年龄3个月至12岁，男4例，女2例，心律失常5例，心功能不全3例，精神差1例，胸闷、叹气1例。4例患儿检测到NVM相关基因变异，其中MYH7基因变异2例，PRDM16基因变异1例，ACTN2基因+TNNT2基因变异1例。心功能改善4例；2例患儿心功能改善不明显，其发病年龄小，超声心动图示收缩功能降低更明显，心肌酶、氨基末端脑钠肽前体升高更明显。NVM是引起儿童慢性心力衰竭的重要原因之一，对于首发有胸闷、叹气、心律失常、心影增大、心肌酶增高明显的患儿，进行超声心动图、心脏磁共振检查，可确诊NVM，NVM可有多种基因变异。
This article summarizes and analyzes the clinical features and gene mutation characteristics of children with noncompaction of the ventricular myocardium (NVM). For the 6 children with NVM (4 boys and 2 girls), the age of onset ranged from 3 months to 12 years. Of the 6 children, 5 had arrhythmia, 3 had cardiac insufficiency, 1 had poor mental state, and 1 had chest distress and sighing. NVM-related gene mutations were detected in 4 children, among whom 2 had MYH7 gene mutation, 1 had PRDM16 gene mutation, and 1 had mutations in the ACTN2 and TNNT2 genes. Four children had improvement in cardiac function. The two children with no significant improvement in cardiac function had a younger age of onset, a greater reduction in systolic function on echocardiography, and greater increases in myocardial enzyme and N-terminal pro-brain natriuretic peptide. It is concluded that for children with the initial symptoms of chest distress, sighing, arrhythmia, enlarged heart shadow, and increased myocardial enzyme, echocardiography and cardiac magnetic resonance are recommended for the diagnosis of NVM. NVM can have various genetic mutations.
Noncompaction of the ventricular myocardium / Gene mutation / Child
[1] 宋开艳, 聂抒, 韩燕燕. 儿童心肌致密化不全[J]. 中华实用儿科临床杂志, 2020, 35(1):70-73.
[2] Jefferies JL, Wilkinson JD, Sleeper LA, et al. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction:results from the pediatric cardiomyopathy registry[J]. J Card Fail, 2015, 21(11):877-884.
[3] Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention[J]. Circulation, 2006, 113(14):1807-1816.
[4] Silvera VM, Gordon LB, Orbach DB, et al. Imaging characteristics of cerebrovascular arteriopathy and stroke in Hutchinson-Gilford progeria syndrome[J]. AJNR Am J Neuroradiol, 2013, 34(5):1091-1097.
[5] 单丽沈, 康鑫源. 左心室心肌致密化不全变异基因的研究进展[J]. 国际儿科学杂志, 2017, 44(1):28-31.
[6] Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction:a step towards classification as a distinct cardiomyopathy[J]. Heart, 2001, 86(6):666-671.
[7] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J].Genet Med, 2015, 17(5):405-424.
[8] 吴洋. 左室心肌致密化不全的心脏磁共振诊断[J]. 心血管病学进展, 2019, 40(5):673-675.
[9] Liu Y, Chen H, Shou W. Potential common pathogenic pathways for the left ventricular noncompaction cardiomyopathy (LVNC)[J]. Pediatr Cardiol, 2018, 39(6):1099-1106.
[10] Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography:persistence of isolated myocardial sinusoids[J]. Am J Cardiol, 1984, 53(11):1733-1734.
[11] Lee TM, Hsu DT, Kantor P, et al. Pediatric cardiomyopathies[J]. Circ Res, 2017, 121(7):855-873.
[12] Long PA, Evans JM, Olson TM. Diagnostic yield of whole exome sequencing in pediatric dilated cardiomyopathy[J]. J Cardiovasc Dev Dis, 2017, 4(3):11.
[13] 赵洁, 王静, 刘丽文, 等. 三维斑点追踪技术对于携带MYH7基因变异的肥厚型心肌病患者预后评估的价值[J]. 中华心血管病杂志, 2020, 48(4):287-293.
[14] Klaassen S, Probst S, Oechslin E, et al. Mutations in sarcomere protein genes in left ventricular noncompaction[J]. Circulation, 2008, 117(22):2893-2901.
[15] Debold EP, Schmitt JP, Patlak JB, et al. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assay[J]. Am J Physiol Heart Circ Physiol, 2007, 293(1):H284-H291.
[16] Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy[J]. J Clin Invest, 1994, 93(1):280-285.
[17] 李雪珍. 肌小节基因变异与扩张型心肌病[J]. 国际儿科学杂志, 2019, 46(2):88-91.
[18] Murphy AC, Young PW. The actinin family of actin crosslinking proteins-a genetic perspective[J]. Cell Biosci, 2015, 5:49.
[19] Finsterer J, Stöllberger C, Towbin JA. Left ventricular noncompaction cardiomyopathy:cardiac, neuromuscular, and genetic factors[J]. Nat Rev Cardiol, 2017, 14(4):224-237.
[20] van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy[J]. J Am Coll Cardiol, 2018, 71(7):711-722.
[21] 康彧, 王竞, 何兰芳, 等. 超声心动图对左心室肌小梁增多伴发心内结构及功能改变的初步研究[J]. 中国超声医学杂志, 2017, 33(3):231-234.
[22] 王策. 儿童心肌致密化不全研究进展[J]. 国际儿科学杂志, 2018, 45(8):601-604.
[23] Kayvanpour E, Sedaghat-Hamedani F, Gi WT, et al. Clinical and genetic insights into non-compaction:a meta-analysis and systematic review on 7598 individuals[J]. Clin Res Cardiol, 2019, 108(11):1297-1308.
